Disclosure of Payments to Healthcare Professionals
Our collaborations with healthcare professionals always aim to benefit patients, improve medical practices and patient care.
Activities can range from clinical research to exchanges on how new medicines fit into patient pathway.
We believe that a more open transparent relationship strengthens the basis for collaboration and is in the best interest of patients and all health stakeholders.
For this reason, we are committed to disclose our interactions with healthcare professionals and organizations through the Disclosure Code de l’EFPIA.
Austria
Public disclosure 2020, 2021, 2022
Public disclosure EFPIA PF BENELUX 2022
Public disclosure PF health BENELUX 2022
Public disclosure PF corporate BENELUX 2022
No Transfer of Value in 2020,2021
Bulgaria
Public disclosure 2020, 2021, 2022
Cyprus
Public disclosure 2021, 2022
No Transfer of Value in 2020
Czech Republic
Public disclosure 2020, 2021, 2022
Denmark
Public disclosure 2020, 2021, 2022
Estonia
No Transfer of Value in 2020, 2021, 2022
Finland
Public disclosure 2020, 2021, 2022
Greece
Report PFD 2020/Report PFD 2021/Report PFD 2022
PFMS Italy Greek Crossborder 2020 /Pierre Fabre Corporate Greek Crossborder 2020/Pierre Fabre Greek Crossborder ToVs 2021/ Pierre Fabre Corporate Greek Crossborder 2022
Report PFMS 2020/Report PFMS 2021/Report PFMS 2022/
Hungary
Public disclosure 2021, 2022
No Transfer of Value in 2020
Lithuania
No Transfer of Value in 2020, 2021, 2022
Luxembourg
Public disclosure 2022
No transfer of Value in 2020, 2021,
Malta
No Transfer of Value in 2020, 2021, 2022
Norway
Public disclosure 2020, 2021, 2022
Poland
Public disclosure HCP 2020, 2021, 2022
Public disclosure HCO 2020, 2021, 2022
Public disclosure R&D 2020, 2021, 2022
Romania
No Transfer of Value in 2020, 2021, 2022
Slovak republic
Public disclosure 2020, 2021, 2022
Sweden
Public disclosure 2020, 2021, 2022
Switzerland
Public disclosure 2020, 2021, 2022
Ukraine
No Transfer of Value in 2020, 2021, 2022
DISCLOSURE METHODOLOGY PIERRE FABRE PHARMACEUTICALS TOV 2023
- The publication provided through this section is made in accordance with the Company Self-Certification 2023 .
- Following European legislation on data privacy, recipients of published transfers of value have a right to access and correct personal data concerning them, which is exercisable by e-mail: transparency.compliance@pierre-fabre.com